Literature DB >> 10759434

Is pulmonary embolism a common cause of chronic pulmonary hypertension? Limitations of the embolic hypothesis.

P Egermayer1, A J Peacock.   

Abstract

The hypothesis that chronic thromboembolic pulmonary hypertension results from unresolved pulmonary embolism has strongly influenced the diagnosis and management of this disease since the 1960s. However, it is nearly impossible to induce chronic pulmonary hypertension in any animal species by means of repeated embolization of thrombotic material. The haemodynamic effects of thrombotic pulmonary embolism of different degrees of magnitude have also been studied in humans and there is little to suggest that chronic pulmonary hypertension is a likely long term outcome. Furthermore many conditions which predispose to venous thromboembolism do not appear to cause thromboembolic pulmonary hypertension. Other arteriopathic and atherosclerotic risk factors, are found in patients with chronic thromboembolic pulmonary hypertension, but not in those with venous thrombosis, suggesting that these may be unrelated conditions. Thrombosis in situ of the pulmonary arteries is common in severe pulmonary hypertension of any cause. Such thrombosis cannot usually be distinguished from pulmonary embolism. It is hypothesized that in situ thrombosis and pulmonary arteriopathy are common causes of vascular occlusion which is usually diagnosed as "chronic thromboembolic pulmonary hypertension" and that venous thromboembolism is unlikely to be a common cause of chronic pulmonary hypertension. It is further hypothesized that pulmonary embolism is seldom the sole cause of "chronic thromboembolic pulmonary hypertension".

Entities:  

Mesh:

Year:  2000        PMID: 10759434     DOI: 10.1034/j.1399-3003.2000.15.03.x

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  23 in total

1.  Pulmonary endarterectomy surgery--a technically demanding cure for WHO Group IV Pulmonary Hypertension: requirements for centres of excellence and availability in Canada.

Authors:  John J Ryan; Stuart Rich; Stephen L Archer
Journal:  Can J Cardiol       Date:  2011-10-22       Impact factor: 5.223

Review 2.  Role of Interventional Radiologist in the Management of Acute Pulmonary Embolism.

Authors:  William Bremer; Charles E Ray; Ketan Y Shah
Journal:  Semin Intervent Radiol       Date:  2020-03-04       Impact factor: 1.513

Review 3.  How I use catheter-directed interventional therapy to treat patients with venous thromboembolism.

Authors:  Suresh Vedantham; Akhilesh K Sista
Journal:  Blood       Date:  2018-01-02       Impact factor: 22.113

4.  Prospective cardiopulmonary screening program to detect chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism.

Authors:  Frederikus A Klok; Klaas W van Kralingen; Arie P J van Dijk; Fenna H Heyning; Hubert W Vliegen; Menno V Huisman
Journal:  Haematologica       Date:  2010-01-06       Impact factor: 9.941

5.  Mid term effects of pulmonary thromboendarterectomy on clinical and cardiopulmonary function status.

Authors:  M C Zoia; A M D'Armini; M Beccaria; A Corsico; P Fulgoni; C Klersy; F Piovella; M Viganò; I Cerveri
Journal:  Thorax       Date:  2002-07       Impact factor: 9.139

6.  Piglet model of chronic pulmonary hypertension.

Authors:  Olaf Mercier; Adriano Tivane; Peter Dorfmüller; Marc de Perrot; François Raoux; Benoît Decante; Saadia Eddahibi; Philippe Dartevelle; Elie Fadel
Journal:  Pulm Circ       Date:  2013-12       Impact factor: 3.017

Review 7.  Coagulation and the vessel wall in pulmonary embolism.

Authors:  Sherin Alias; Irene M Lang
Journal:  Pulm Circ       Date:  2013-12       Impact factor: 3.017

8.  The erythrocyte: a new player in atheromatous core formation.

Authors:  G Pasterkamp; R Virmani
Journal:  Heart       Date:  2002-08       Impact factor: 5.994

Review 9.  Current concepts in the pathogenesis of chronic thromboembolic pulmonary hypertension.

Authors:  Daniel T Matthews; Anna R Hemnes
Journal:  Pulm Circ       Date:  2016-06       Impact factor: 3.017

Review 10.  [Right heart failure and cor pulmonale].

Authors:  M Leschke; A Wädlich
Journal:  Internist (Berl)       Date:  2007-09       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.